Access HBV Assays - European Union (EU) Clinical Trial Protocol - | MicrobiomeTrials← Back to trialsNCT04904835
Access HBV Assays - European Union (EU) Clinical Trial Protocol -
CompletedOBSERVATIONAL
Trial Details
Start: 2019-10-15Est. Completion: 2025-12-09
Enrollment target: 21,210 participants Locations- Centre de Ressources Biologiques Biobanque de Picardie CHU Amiens-Picardie, Amiens, France
- Etablissement Français du Sang (EFS) Hauts-de-France - Normandie, Bois-Guillaume, France
- Cerba Xpert, Frépillon, France
- Eurofins Biomnis, Ivry-sur-Seine, France
- Laboratoire de Virologie, Laboratoire associé au CNR du VIH Institut de Biologie Clinique ; hôpital C : Nicolle, CHU Rouen, Rouen, France
Other microbiome trials you might be interested in
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
Background:
\- Chronic infection with the hepatitis B virus may lead to cirrhosis, liver disease, and cancer of the liv…
Bethesda, United States
Hepatitis CHepatitis B
This study will evaluate hepatitis C virus (HCV) infection in blood donors who test positive for antibodies to this viru…
Bethesda, United States
TERMINATED
This Phase 1/2a multiple part study is a first time-in-human (FTIH) study designed to evaluate the safety, tolerability,…
Calgary, CanadaCompleted May 19, 2025